Has stated belief in power of CBD products, but will not support medical or recreational marijuana without "more research." (Letter to constituent, 6/21/21)
Holds office U.S. House District 4
When asked by a constituent about marijuana legalization, Rep. Feenstra responded, "Congress's decision to place marijuana as a Schedule I drug reflects the legislative finding that marijuana has a high potential for abuse, and I agree with this classification."
It's obvious Rep. Feenstra hasn't done their research. We implore them to educate themselves on the truth about marijuana.
2021: The Medical Marijuana Research Act, HR 5657
2021: The MORE Act, HR 3617
2021: The SAFE Banking Act, HR 1996
1440 Longworth House Office Building
Washington, DC 20515